K., Culmsee, C., Plesnila, N., Kremmer, E., Radmark, O., Wurst, W., Bornkamm, G
GLP-1 RAs use was significantly associated with a lower risk of HHF in patients with a history of HF (HR 0.65
Andersen JV (2025) The glutamate/GABAglutamine cycle: insights, updates, and advances
This struggle can lead to feelings of frustration and inadequacy, especially when they are doing everything "right." The introduction of GLP-1 agonists into our treatment protocols has been a game-changer, allowing these individuals to regain control over their weight and, consequently, their lives
AOD-9604 works by stimulating lipolysis and inhibiting lipogenesis in adipose tissue, effects traditionally attributed to the C-terminal region of growth hormone